A federal judge in Texas rejected a bid by compounding pharmacies to allow them to continue making copies of Novo Nordisk's blockbuster drugs Ozempic and Wegovy, upholding the U.S. Food and Drug Administration's decision to remove the drugs' active ingredient from the shortage list https://reut.rs/406BYrR